COVID-19 Vaccine Updates

760-291-6700

COVID-19 VACCINE UPDATES

Updated Guidance Regarding COVID-19 Booster Shots

The CDC recently issue the following update on  COVID-19 vaccine booster shots:

If you previously got 2 doses of the Pfizer-BioNTech COVID-19 vaccine, you can get a booster shot of the Pfizer-BioNTech COVID-19 vaccine if you fall into one of these groups:

You can get your booster shot at least 6 months after you complete your second dose of the Pfizer vaccine. The booster shot can help strengthen and prolong your protection against COVID-19.

Learn more about who is eligible to receive a COVID-19 booster shot here.

Visit CDC.gov for more information on other groups already vaccinated with the Pfizer vaccine that may be eligible for a booster shot.

Remember: The COVID vaccine and COVID booster shot are available for everyone at no cost.

To find out where and how to get a COVID-19 booster shot, visit My Turn – California COVID-19 Vaccine Scheduling & Notifications or https://myturn.ca.gov. Palomar Health Medical Group – Graybill and Graybill Medical Group are not administering COVID-19 vaccines or COVID-19 booster sho

CDC: Delta Variant – What We Know About the Science

To maximize protection from the Delta variant and prevent possibly spreading it to others, get vaccinated as soon as you can and wear a mask indoors in public if you are in an area of substantial or high transmission.

Read more…

Get the Facts on Vaccines (ca.gov)

Downloadable Fact Sheets in Multiple Languages Additional Resources. Three COVID-19 vaccines have been authorized by the FDA for emergency use, given the severity of the COVID-19 pandemic.

Important News: Masks Are Still Required

In accordance with CDC and Cal-OSHA current guidelines, as a healthcare setting, masks and social distancing are still required inside all Graybill facilities. We thank you for your cooperation.

For more on the current CDC guidelines, see https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/guidance-for-face-coverings.aspx

Read the latest updates regarding COVID-19 vaccine availability and distribution.

Federal Retail Pharmacy Program for COVID-19 Vaccination

Pharmacists are highly trusted and trained healthcare providers who have direct access to and knowledge of their patient populations. Pharmacists are trained to counsel patients, administer vaccine, and provide vaccine education, and pharmacies are readily accessible in communities – with most Americans living within five miles of a pharmacy. Recognizing this, the federal government has made pharmacies a key part of its COVID-19 vaccination strategy. While the program will ultimately expand to include more than 40,000 pharmacies, it is important to know that early on, when vaccine supply is still limited, many pharmacies may not have vaccine or may have very limited supply.

Here is a link for Retail Pharmacies that are receiving federal allocations of the Moderna, Pfizer and Janssen COVID Vaccines. The link also includes pharmacy scheduling links.

https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/FedRetailPharmProgVacAppt.aspx 

Graybill COVID-19 Vaccine Program Discontinued

Due to changes in the State of California COVID-19 vaccine distribution program, Graybill Medical Group’s COVID-19 vaccine program has been discontinued. For information on how and where to get vaccinated, go to:

  • Myturn.ca.gov – Register here to receive updates about new appointments and locations. Note: My Turn is available in eight languages, and for those without internet access, appointments can be made by calling (833) 422-4255. The hotline is available in English and Spanish, with third party translators available in more than 250 additional languages.
  • Vaccinefinder.org – Find a nearby location where you can receive the COVID-19 vaccine
PUBLIC HEALTH AGENCY UPDATES

U.S. Centers for Disease Control and Prevention (CDC)

California Department of Public Health

San Diego County Department of Public Health

Riverside County Public Health

GRAYBILL COVID-19 UPDATES

Screening Mammography Guidance for COVID-19 Vaccine Related Adenopathies The Graybill Radiology Department would like to share the following regarding screening mammography and recently published recommendations for best management during the pandemic.

In response to evidence published last week in Clinical Imaging that the two approved COVID-19 vaccines (Pfizer & Moderna) can potentially lead to axillary adenopathies that can mimic breast malignancies. Moving forward our Radiology Department will advise all patients scheduling screening mammograms of the following recommendation by the Society of Breast Imaging.

“When possible – being sure not to unduly delay care – schedule screening exams before the first vaccine dose or four-to-six weeks after the second dose.” – SBI 1/26/21

References:

https://www.diagnosticimaging.com/view/sbi-publishes-management-guidance-for-covid-19-vaccine-related-adenopathies
https://www.clinicalimaging.org/article/S0899-7071(21)00020-6/fulltext?dgcid=raven_jbs_aip_email

 

Menu